BLIS Technologies Limited AI Stock Analysis
Want to see NZ:BLT full AI Analyst Report?
BLIS Technologies Limited (BLT) AI Stock Analysis
BLIS Technologies Limited
(NZX:BLT)
The score is driven primarily by improving financial performance and strong revenue momentum, supported by a conservatively levered balance sheet. The biggest offsets are weakened FY2026 cash flow (negative operating and free cash flow) and compressed margins, while the stock also appears overbought technically and carries a high P/E that increases downside sensitivity if execution slips.
BLIS Technologies Limited (BLT) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- NZD 31.34M
- Dividend Yield
- ―
- Average Volume (3M)
- 448.75K
- Price to Earnings (P/E)
- 48.0
- Beta (1Y)
- 0.49
- Revenue Growth
- 16.01%
- EPS Growth
- -28.57%
- Country
- NZ
- Employees
- 43
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
BLIS Technologies Limited Business Overview & Revenue Model
Company Description
BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently featur...
BLIS Technologies Limited Financial Statement Overview
Summary
Revenue growth has accelerated strongly through FY2026 and the company has returned to positive net income. Offsetting this, FY2026 shows sharp margin compression (gross margin down to ~43% and EBIT margin ~4%) and a deterioration in cash generation with negative operating cash flow and free cash flow, raising near-term execution and funding-risk concerns despite low leverage.
Income Statement
68PositiveBalance Sheet
82Very PositiveCash Flow
44Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.67M | 14.67M | 11.56M | 10.48M | 9.96M | 8.80M |
| Gross Profit | 6.40M | 6.25M | 9.01M | 8.23M | 7.77M | 6.87M |
| EBITDA | 1.09M | 1.08M | 1.49M | 1.25M | -746.00K | -2.02M |
| Net Income | 692.00K | 692.00K | 838.00K | 646.00K | -1.35M | -2.71M |
Balance Sheet | ||||||
| Total Assets | 14.97M | 14.97M | 14.30M | 12.93M | 12.81M | 14.14M |
| Cash, Cash Equivalents and Short-Term Investments | 8.51M | 8.51M | 9.73M | 8.60M | 8.35M | 8.59M |
| Total Debt | 439.00K | 439.00K | 589.00K | 389.00K | 619.00K | 754.00K |
| Total Liabilities | 1.93M | 1.93M | 1.97M | 1.45M | 1.97M | 1.99M |
| Stockholders Equity | 13.04M | 13.04M | 12.32M | 11.49M | 10.84M | 12.15M |
Cash Flow | ||||||
| Free Cash Flow | -720.00K | -720.00K | 1.31M | 486.00K | 9,000 | -2.57M |
| Operating Cash Flow | -595.00K | -595.00K | 1.79M | 1.05M | 106.00K | -2.31M |
| Investing Cash Flow | 451.00K | 451.00K | -1.68M | -819.00K | -4.10M | -262.00K |
| Financing Cash Flow | -147.00K | -147.00K | -217.00K | -224.00K | -275.00K | 8.92M |
BLIS Technologies Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:BLT, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and above the 200-day MA of 0.02, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 40.16 is Neutral, neither overbought nor oversold. The STOCH value of -200.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:BLT.
BLIS Technologies Limited Peers Comparison
Overall Rating
NZ:PHL63Neutral
NZ:BLT60Neutral
NZ:TAH58Neutral
NZ:RAD56Neutral
NZ:RUA41.5Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 63Neutral | NZD 33.62M | 0.03 | ― | ― | 15.19% | 1154.17% | |
| 60Neutral | NZD 31.98M | 48.00 | ― | ― | 16.01% | -28.57% | |
| 58Neutral | NZD 37.83M | 11.70 | ― | 4.15% | 21.56% | 18.96% | |
| 56Neutral | NZD 113.39M | 10.18 | ― | 6.03% | 9.76% | -1.75% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 42Neutral | NZD 11.77M | -2.60 | ― | ― | 70.82% | 41.04% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NZ:BLT | BLIS Technologies Limited | 0.02 | 0.01 | 60.00% | |
| NZ:PHL | Promisia Healthcare Limited | 0.62 | 0.06 | 11.71% | |
| NZ:TAH | Third Age Health Services Limited | 3.86 | -1.74 | -31.12% | |
| NZ:RAD | Radius Residential Care Ltd | 0.40 | 0.02 | 4.99% | |
| NZ:RUA | Rua Bioscience Ltd. | 0.03 | -0.00 | -3.70% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 05, 2026
